Investors might want to bet on Intensity Therapeutics Inc. (INTS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
The lesson of the day is that when the Minnesota Vikings are involved, it can always get worse. J.J. McCarthy had struggled so mightily over the past three weeks, culminating in last week's lifeless ...
San Francisco 49ers quarterback Brock Purdy threw three interceptions across his team's first four drives against the Carolina Panthers. It's the first time a player has thrown three interceptions on ...
Fintel reports that on August 12, 2025, Brookline Capital upgraded their outlook for Intensity Therapeutics (NasdaqCM:INTS) from Hold to Buy. Analyst Price Forecast Suggests 2,017.77% Upside As of ...
ThinkEquity analyst initiated coverage with a Buy rating on Intensity Therapeutics, Inc. yesterday and set a price target of $3.00. The company’s shares closed yesterday at $0.34. Take advantage of ...
Java defies the hype cycle, thriving at 30 with unmatched enterprise trust, modern AI integration, and a vibrant, global developer community. In a fast-paced tech landscape where languages rise and ...
MIAMI GARDENS — The first Miami Dolphins training camp practice open to fans was relatively lightly-attended Saturday. Perhaps it’s the earlier start time this season — 9 a.m. instead of roughly 10:40 ...
NEW ORLEANS -- Patrick Mahomes said during the week that the most disappointing loss of his career came in Super Bowl LV following the 2020 season, when the Kansas City Chiefs fell to the Tampa Bay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback